These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1742 related items for PubMed ID: 26858942

  • 1. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ, Chen X, Hu T, Meng C, Wang XB, Rao Y, Zhang XM, Yin YL, Pan ZM, Jiao XA.
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH, He HY, Zhang FJ.
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.
    Deng YH, He HY, Zhang BS.
    J Microbiol Immunol Infect; 2014 Feb; 47(1):48-56. PubMed ID: 23357605
    [Abstract] [Full Text] [Related]

  • 4. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X, Teng X, Jing Y, Ma J, Tian M, Yu Q, Zhou L, Wang R, Wang W, Li L, Fan X.
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunogenicity and protective efficacy of a novel recombinant BCG strain overexpressing antigens Ag85A and Ag85B.
    Wang C, Fu R, Chen Z, Tan K, Chen L, Teng X, Lu J, Shi C, Fan X.
    Clin Dev Immunol; 2012 Dec; 2012():563838. PubMed ID: 22570667
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rapid loss of early antigen-presenting activity of lymph node dendritic cells against Ag85A protein following Mycobacterium bovis BCG infection.
    Xu Z, Xia A, Li X, Zhu Z, Shen Y, Jin S, Lan T, Xie Y, Wu H, Meng C, Sun L, Yin Y, Chen X, Jiao X.
    BMC Immunol; 2018 Jun 25; 19(1):19. PubMed ID: 29940854
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein.
    Deng Y, Bao L, Yang X.
    Microbiol Immunol; 2011 Nov 25; 55(11):798-808. PubMed ID: 21831202
    [Abstract] [Full Text] [Related]

  • 14. Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice.
    Yang E, Lu Y, Xu Y, Liang Q, Wang C, Wang H, Shen H.
    Microb Pathog; 2014 Nov 25; 69-70():53-9. PubMed ID: 24726737
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
    Tang C, Yamada H, Shibata K, Maeda N, Yoshida S, Wajjwalku W, Ohara N, Yamada T, Kinoshita T, Yoshikai Y.
    J Infect Dis; 2008 May 01; 197(9):1263-74. PubMed ID: 18422438
    [Abstract] [Full Text] [Related]

  • 18. Heterologous Boost Following Mycobacterium bovis BCG Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection.
    Wu Y, Cai M, Ma J, Teng X, Tian M, Bassuoney EBMB, Fan X.
    Front Immunol; 2018 May 01; 9():2439. PubMed ID: 30425711
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dose of incorporated immunodominant antigen in recombinant BCG impacts modestly on Th1 immune response and protective efficiency against Mycobacterium tuberculosis in mice.
    Ma H, Wu K, Liu F, Yang H, Kang H, Chen NN, Yuan Q, Zhou WJ, Fan XY.
    J Immunol Res; 2014 May 01; 2014():196124. PubMed ID: 25152895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 88.